The Union health ministry on Friday said license has been given to five more manufacturers for production of Amphotericin-B, used in the treatment of black fungus, and they will start producing......
Amid surging COVID-19 cases in the country, the government on Tuesday waived customs duty on Remdesivir, its raw materials and other components used to make the antiviral drug. The move would help......
The government plans to double the production of antiviral drug remdesivir to around 3 lakh vials per day over the next 15 days, to make it available readily for the treatment of COVID-19.......
Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With more drugmakers in line to launch the drug soon, the prices may see a further erosion. Sohini Das reports. IMAGE: An......
The antiviral drug may cost around Rs 55,000 for an 11-dose course, or Rs 5,000 per injection -- much less than the price of imports from Bangladesh, reports Sohini Das. Image used for......
Cadila, Biocon developing rapid antibody testing kits; Eris, Mylan, Gland importing. Indian pharma majors are gearing up to develop or import testing kits for the novel coronavirus as demand for......
While companies continue to face regulatory pressure leading to higher costs, they see an uptick from the launch of differentiated and high-margin products. Illustration: Uttam Ghosh/Rediff.com......
Dr Reddy’s, Glenmark, Wockhardt have lined up alternatives for Zytiga With pharmaceutical major Johnson & Johnson (J&J) losing the patent battle in the US court for its popular prostrate......
Rare deal of a Chinese drug firm buying an Indian company likely this week Hong Kong-listed Shanghai Fosun Pharmaceutical (Group) has agreed to buy Hyderabad-based Gland Pharma, backed by private......
The US Food and Drug Administration warned Novartis AG last week after the Swiss firm was found in violation of manufacturing practices last year at two of its India drug-making plants, Novartis......